LSD-assisted psychotherapy in patients with terminal cancer.
D000328:Adult; D000368:Aged; D001007:Anxiety / Q000188:drug therapy; D001293:Attitude to Death; D002986:Clinical Trials as Topic; D003863:Depression / Q000628:therapy; D005260:Female; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects / Q000627:therapeutic use*; D008950:MMPI; D008297:Male; D008875:Middle Aged; D009294:Narcotics / Q000008:administration & dosage / Q000627:therapeutic use; D009369:Neoplasms / Q000451:nursing* / Q000628:therapy; D010166:Palliative Care; D011569:Psychiatric Status Rating Scales; D011613:Psychotherapy; D013727:Terminal Care; D014363:Tryptamines / Q000009:adverse effects / Q000627:therapeutic use
D009294:Narcotics; D014363:Tryptamines; D008238:Lysergic Acid Diethylamide